How do genetic, clinical and treatment factors affect outcome in severe mental disorder
- Prosjektnummer
- 911820
- Ansvarlig person
- Erik Johnsen
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Nasjonal satsing, Alvorlige psykiske lidelser
- Helsekategori
- Mental Health
- Forskningsaktivitet
- 1. Underpinning, 6. Treatment Evaluation
Dette prosjektet ble starter før brukermedvirkning var etablert som fast praksis. Imidlertid har Bergen Psychosis Research Group, som er forskergruppen ansvarlig for prosjektet, siden 2016 etablert referansegruppe erfaringskompetans ift psykoseforskning. Denne referansegruppen deltar i møter som omhandler alle faser av forskning knyttet til BPRG.
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement.
PLoS One 2016;11(12):e0167390. Epub 2016 des 15
PMID: 27977720
Suicidality in schizophrenia spectrum disorders: the relationship to hallucinations and persecutory delusions.
Eur Psychiatry 2015 Oct;30(7):830-6. Epub 2015 sep 25
PMID: 26443050
Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: a (1)H MRS study.
Schizophr Res 2015 Feb;161(2-3):252-60. Epub 2014 des 24
PMID: 25542859
Auditory verbal hallucinations reflect stable auditory attention deficits: a prospective study.
Cogn Neuropsychiatry 2015;20(1):81-94.
PMID: 25384552
Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies.
Ther Adv Psychopharmacol 2014 Dec;4(6):228-39.
PMID: 25489474
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.
Front Psychiatry 2014;5():159. Epub 2014 nov 18
PMID: 25477825
Cognitive changes in patients with acute phase psychosis--effects of illicit drug use.
Psychiatry Res 2014 Dec 30;220(3):818-24. Epub 2014 sep 8
PMID: 25240944
Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia.
Neuroimage Clin 2014;4():576-84. Epub 2014 apr 2
PMID: 24749064
A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.
Front Psychiatry 2014;5():11. Epub 2014 feb 4
PMID: 24550848
Stratified medicine for mental disorders.
Eur Neuropsychopharmacol 2014 Jan;24(1):5-50. Epub 2013 okt 4
PMID: 24176673
Dichotic listening, executive functions and grey matter cortical volume in patients with schizophrenia and healthy controls.
Scand J Psychol 2013 Oct 9. Epub 2013 okt 9
PMID: 24117463
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
BMC Psychiatry 2013;13():241. Epub 2013 sep 30
PMID: 24079855
Failure of attention focus and cognitive control in schizophrenia patients with auditory verbal hallucinations: evidence from dichotic listening.
Schizophr Res 2013 Jul;147(2-3):301-9. Epub 2013 mai 9
PMID: 23664588
The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations.
Front Hum Neurosci 2013;7():144. Epub 2013 apr 24
PMID: 23630479
Prospective and concurrent correlates of emotion perception in psychotic disorders: a naturalistic, longitudinal study of neurocognition, affective blunting and avolition.
Scand J Psychol 2013 Jun;54(3):261-6. Epub 2013 mar 1
PMID: 23448554
Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.
Expert Rev Neurother 2013 Jan;13(1):23-36.
PMID: 23253389
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Eur Psychiatry 2013 Mar;28(3):174-84. Epub 2011 des 6
PMID: 22153730
QTc prolongation in patients acutely admitted to hospital and treated with second generation antipsychotics.
Sch Res Treat 2013; doi:10.1155/2013/375020
The influence of glutamatergic antagonism on motor variability in healthy subjects, and comparison to findings in schizophrenia
Acta Neuropsychiatr 2013;25:105-12. DOI:10.1111/j.1601-5215.2012.00674.x
Antipsychotic drug treatment of patients with schizophrenia. Practice and effectiveness.
- Disputert:
- januar 2013
- Hovedveileder:
- Erik Johnsen
- Igne Sinkeviciute Ph.d.-kandidat
- Solveig Klæbo Reitan Prosjektleder
- Else-Marie Løberg Prosjektleder
- Rune Andreas Kroken Prosjektleder
- Kenneth Hugdahl Leder av forskningsgruppe
- Vidar Martin Steen Leder av forskningsgruppe
- Ole Andreas Andreassen Leder av forskningsgruppe
- Inge Joa Leder av forskningsgruppe
- Erik Johnsen Prosjektleder
- Liss Gøril Anda-Ågotnes Ph.d.-kandidat
- Vidje Hansen Prosjektleder
- Gunnar Morken Prosjektleder
- Ingrid Melle Prosjektleder
- Ole Bernt Fasmer Prosjektdeltaker
- Ketil Joachim Ødegaard Prosjektdeltaker
- Silje Skrede Prosjektdeltaker
- Farivar Fathian Ph.d.-kandidat
- Eirik Kjelby Ph.d.-kandidat
- Siri Helle Ph.d.-kandidat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest